Early diagnosis model of mycosis fungoides and five inflammatory skin diseases based on multi-modal data-based convolutional neural network.

in The British journal of dermatology by Zhaorui Liu, Yilan Zhang, Ke Wang, Fengying Xie, Jie Liu

TLDR

  • Researchers developed an AI-powered tool to diagnose mycosis fungoides (MF) and similar skin conditions, achieving higher accuracy rates than doctors alone.
  • The AI model uses multimodal information to diagnose MF and similar skin conditions, showing great potential for improved diagnostic accuracy.

Abstract

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma, and early-stage MF is difficult to differentiate from erythematous inflammatory disease. Except biopsy, non-invasive information such as patient's basic information, clinical images and dermoscopic images is of great significance for early diagnosis of MF. However, there is still a lack of diagnosis models based on convolutional neural network that can utilize the above multimodal information. We aim to develop an artificial intelligence (AI) deep learning model based on multimodal information, verify its classification efficiency, and construct an AI-aided early diagnostic model of MF and inflammatory skin diseases for dermatologists. This is a single center retrospective study based on multimodal information including clinical information, clinical images, and dermoscopic images. A total of 1157 cases of MF and inflammatory diseases were collected, including 2452 clinical images, 6550 dermoscopic images and corresponding clinical data. RegNetY-400MF was selected as the feature extractors in the study. AI model demonstrates higher levels of total accuracy, precision, sensitivity, and specificity in classification of MF and other inflammatory skin diseases compared to the participating dermatologists. A significant enhancement was noticed in average accuracy, sensitivity, and specificity for MF and inflammatory diseases within the Doctor+AI group, with values of 82.94%, 86.16%, and 96.45% respectively, compared to 71.52%, 74.56%, and 94.06% within the Doctor-only group. The more accurately diagnosis of each disease was also achieved by the multi-classification model. These results indicate that our AI model has a significantly strong discriminative ability to assist doctors in improving diagnostic accuracy of early-stage MF and common inflammatory skin diseases.

Overview

  • The study aims to develop an artificial intelligence (AI) deep learning model to diagnose mycosis fungoides (MF) and inflammatory skin diseases using multimodal information, including clinical information, clinical images, and dermoscopic images.
  • The study collected 1157 cases of MF and inflammatory diseases, including 2452 clinical images, 6550 dermoscopic images, and corresponding clinical data.
  • The primary objective of the study is to construct an AI-aided early diagnostic model of MF and inflammatory skin diseases for dermatologists.

Comparative Analysis & Findings

  • The AI model demonstrated higher levels of total accuracy, precision, sensitivity, and specificity in classification of MF and other inflammatory skin diseases compared to participating dermatologists.
  • The AI model achieved an average accuracy, sensitivity, and specificity of 82.94%, 86.16%, and 96.45%, respectively, compared to 71.52%, 74.56%, and 94.06% for doctors who only used their expertise.
  • The multi-classification model accurately diagnosed each disease, indicating the strong discriminative ability of the AI model to assist doctors in improving diagnostic accuracy.

Implications and Future Directions

  • The study demonstrates the potential of AI-based diagnosis for improving diagnostic accuracy and efficiency in dermatological practice.
  • Future studies can explore the application of this AI model in real-world clinical settings and its potential to reduce the risk of misdiagnosis.
  • The study highlights the need for further research on the development of AI-aided diagnosis models for other skin diseases and the potential for AI to complement clinical expertise.